Regional Agricultural Biotechnology Network
Near East and North Africa
home
Home
|contact
Contacts
|
Fao
Search:
Browse By:
Egypt Saudi Arabia Oman Tunisia Lebanon Jordan Iraq Morocco Cyprus Qatar Iran Syria Sudan Yemen Kuwait U.A.E turkey FAO Agricultural Biotechnologies Country
Country
Institutions
Disciplines

Language
Workshop Presents Differences of Traditional and Modern Biotech
Date
From 24 August 2015 To 25 August 2015
Location
Cairo,Egypt
Type
Regional - Workshop
Cooperating OrganizationsNational Gene Bank

The Federation of Arab Scientific Research Councils with the Academy of Scientific Research and Technology organized the 6th International Arab Workshop on Biotechnology which was held at the National Research Center on August 24-25, 2015 under the auspices of the Minister of Scientific Research and the President of Academy of Scientific Research and Technology. More than 200 participants attended the workshop, including scientists from Sudan, Tunisia, and Jordan. Prof. Andreas Börner from Leibniz Institute of Plant Genetics and Crop Plant gave a presentation on their gene bank management and seed materials reproduction. Dr. Hanaiya El-Itraby talked about the activities in the National Gene Bank in Egypt and how they play a crucial role in preserving the biodiversity.

Dr. Naglaa Abdallah, Director of EBIC gave a presentation on the challenges and opportunities of genome editing for crops improvement. She compared this newly developed technique with mutagenesis, and genetic modification. According to Dr. Abdallah, although genome-editing technologies promise to be more efficient and precise to edit genes, it is in its early stage and could not replace GM crops completely. GM crops may have some disadvantages such as regulatory delays, cost and time to launch, but until now it is the technique of choice.

Concerning the regulatory system she added, "Many of these techniques could cause variation in the genotype that is indistinguishable from the natural means or conventional mutagenesis; and therefore, they do not fit current definitions of GMO used within most regulatory regimes. Regulation will focus on the process used, rather than the nature of the novel phenotype developed."
Back